Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anabela Barcelos

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switchingLouise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
Acta Reumatologica Portuguesa|November 11, 2006
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]João Eurico Fonseca, Helena Canhão, Cândida Silva, et al.
ARP Rheumatology|January 2, 2026
Interstitial lung disease in Sjögren's disease: the portrait of a national cohortAna Catarina Duarte, Susana Matias, Carolina Bargado, et al.
Arthritis Care & Research|January 13, 2015
Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus CohortLuís Inês, Cândida Silva, Maria Galindo, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Annals of the Rheumatic Diseases|August 22, 2019
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, et al.
Acta Reumatologica Portuguesa|September 13, 2017
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 updatePedro Machado, Marcos Cerqueira, Pedro Ávila-Ribeiro, et al.
Rheumatology (Oxford, England)|December 23, 2021
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and responseSara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, et al.
Joint Bone Spine|April 6, 2024
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatmentLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|September 22, 2023
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switchingLouise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, et al.
Acta Reumatologica Portuguesa|November 11, 2006
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]João Eurico Fonseca, Helena Canhão, Cândida Silva, et al.
ARP Rheumatology|January 2, 2026
Interstitial lung disease in Sjögren's disease: the portrait of a national cohortAna Catarina Duarte, Susana Matias, Carolina Bargado, et al.
Arthritis Care & Research|January 13, 2015
Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus CohortLuís Inês, Cândida Silva, Maria Galindo, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Annals of the Rheumatic Diseases|August 22, 2019
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, et al.
Acta Reumatologica Portuguesa|September 13, 2017
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 updatePedro Machado, Marcos Cerqueira, Pedro Ávila-Ribeiro, et al.
Rheumatology (Oxford, England)|December 23, 2021
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and responseSara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, et al.
Joint Bone Spine|April 6, 2024
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatmentLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, et al.
Pageof 7